<DOC>
	<DOCNO>NCT00572156</DOCNO>
	<brief_summary>IGF-1 ( insulin-like growth factor-1 ) hormone normally produce body response another hormone call growth hormone . Growth Hormone produce small gland base brain ( pituitary ) . Together IGF-1 GH large contributor growth infancy , childhood , adolescence . Children IGF Deficiency short imbalance level growth hormone IGF-1 body produce . Their growth hormone level normal even high , IGF-1 level increase normally response growth hormone . As result , type growth hormone insensitivity inability grow normally . This study test see whether daily dose combination rhIGF-1 rhGH help child IGFD grow taller quickly child treat rhGH alone . The study medication , rhIGF-1 rhGH , approve US Food Drug Administration ( FDA ) use growth disorder child , combination rhIGF-1 rhGH child IGF-1 deficiency ( IGFD ) investigational .</brief_summary>
	<brief_title>rhGH rhIGF-1 Combination Therapy Children With Short Stature Associated With IGF-1 Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism</mesh_term>
	<criteria>Parents legally authorize representative must give sign informed consent trialrelated activity IGF1 SDS ≤ 1 age gender Short stature , define height SDS ≤ 2 age gender Chronological age ≥ 5 year Bone age ≤ 11 year boys ≤ 9 year girls GH sufficiency , define maximal stimulated GH response great equal 10 ng/mL Visit 2 ( note : upon approval Medical Monitor , result prior GH stimulation test may satisfy requirement ) . Prepubertal status Adequate nutrition evidence body mass index ( BMI ) great equal 5th percentile age gender Severe Primary IGFD ( define height IGF1 SDS ≤ 3 , stimulate GH response great equal 10 ng/mL ) Prior current use medication potential alter growth pattern include GH , IGF1 , IGFBP3 , gonadotrophin agonist ( e.g. , Lupron ) , aromatase inhibitor , androgen estrogens Known suspect allergy rhGH , rhIGF1 constituent formulation Current use medication attention deficit disorder A chronic health condition require antiinflammatory steroid daily medication unless approve Medical Monitor</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>IGF-1 Deficiency</keyword>
	<keyword>growth</keyword>
	<keyword>ISS</keyword>
	<keyword>Constitutional growth delay</keyword>
	<keyword>Primary IGFD</keyword>
	<keyword>Primary IGF Deficiency</keyword>
</DOC>